{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:54:19Z","timestamp":1791975259124,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.kint.2016.06.026","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:41:06Z","timestamp":1471999266000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Antiphospholipid syndrome and kidney disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Frank","family":"Bienaim\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.06.026_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.06.026_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0272-6386(12)80543-9","article-title":"Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"20","author":"Hughson","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2016.06.026_bib4","first-page":"1181","article-title":"Renal involvement in primary antiphospholipid syndrome","volume":"19","author":"Amigo","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0046-8177(95)90218-X","article-title":"Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome","volume":"26","author":"Hughson","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2016.06.026_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000188231","article-title":"Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review","volume":"68","author":"Domrongkitchaiporn","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2016.06.026_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0272-6386(12)80909-7","article-title":"Primary antiphospholipid syndrome and self-limited renal vasculitis during pregnancy: case report and review of the literature","volume":"24","author":"Almeshari","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid syndrome nephropathy in systemic lupus erythematosus","volume":"13","author":"Daugas","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib10","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","article-title":"The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury","volume":"93","author":"Griffiths","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.kint.2016.06.026_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","article-title":"The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features","volume":"14","author":"Abreu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2016.06.026_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.06.026_bib14","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1600-6143.2011.03696.x","article-title":"Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation","volume":"11","author":"Hadaya","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/ajt.12319","article-title":"Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes","volume":"13","author":"Canaud","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.49.3.184","article-title":"Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome","volume":"49","author":"Ostuni","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/31.2.117","article-title":"Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the 'primary' antiphospholipid syndrome","volume":"31","author":"Ames","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0272-6386(96)90109-2","article-title":"Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome","volume":"27","author":"Poux","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00004728-199909000-00005","article-title":"CT features of abdominal manifestations of primary antiphospholipid syndrome","volume":"23","author":"Kim","year":"1999","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.kint.2016.06.026_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0895-7061(00)00296-X","article-title":"Hypertension due to renal artery occlusion in a patient with antiphospholipid syndrome","volume":"14","author":"Riccialdelli","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2016.06.026_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000046220","article-title":"Acute renal failure in a renal transplant donor due to primary antiphospholipid syndrome","volume":"21","author":"Chitalia","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/s101650170030","article-title":"Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis","volume":"11","author":"Saji","year":"2001","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib23","first-page":"196","article-title":"Antiphospholipid syndrome with renal artery embolism: case report","volume":"3","author":"Safley","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.kint.2016.06.026_bib24","first-page":"874","article-title":"Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome","volume":"20","author":"Asherson","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1464-410X.1994.tb07137.x","article-title":"Renal vein thrombosis caused by primary antiphospholipid syndrome","volume":"74","author":"Morgan","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.kint.2016.06.026_bib26","first-page":"56","article-title":"Primary antiphospholipid syndrome presented by total infarction of right kidney with nephrotic syndrome","volume":"52","author":"S\u00e1","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib27","first-page":"1929","article-title":"Renal vein thrombosis as first clinical manifestation of the primary antiphospholipid syndrome","volume":"10","author":"Ko","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/ard.56.9.562","article-title":"Renal vein thrombosis in Chinese patients with systemic lupus erythematosus","volume":"56","author":"Lai","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib29","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.revmed.2011.01.006","article-title":"[Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? Comment on the article by Szymezak et\u00a0al]","volume":"32","author":"Zenone","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.kint.2016.06.026_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.1998.tb00995.x","article-title":"Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies","volume":"12","author":"Vaidya","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib32","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70009-0","article-title":"Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus","volume":"34","author":"Stone","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib33","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.TP.0000119157.81765.46","article-title":"Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome","volume":"77","author":"Vaidya","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.06.026_bib34","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1600-6143.2010.03233.x","article-title":"Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies","volume":"10","author":"Canaud","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar4549","article-title":"Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers","volume":"16","author":"Meroni","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2016.06.026_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/096120339600500524","article-title":"In\u00a0vivo models of thrombosis for the antiphospholipid syndrome","volume":"5","author":"Pierangeli","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"Jankowski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2","volume":"121","author":"Ramesh","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.06.026_bib39","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","article-title":"beta(2)-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"Arad","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.kint.2016.06.026_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.kint.2016.06.026_bib42","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jth.12722","article-title":"Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome","volume":"12","author":"Arachchillage","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2016.06.026_bib43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2013.08.015","article-title":"Receptors involved in cell activation by antiphospholipid antibodies","volume":"132","author":"Brandt","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.kint.2016.06.026_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0049-3848(93)90176-O","article-title":"Inhibition of heparin\/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis","volume":"71","author":"Chamley","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.kint.2016.06.026_bib45","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.4049\/jimmunol.167.12.7192","article-title":"Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin","volume":"167","author":"Hwang","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2016.06.026_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1200\/JCO.2005.02.2418","article-title":"High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma","volume":"24","author":"Abdel-Rahman","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.kint.2016.06.026_bib47","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.4049\/jimmunol.182.3.1674","article-title":"Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin","volume":"182","author":"Yang","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2016.06.026_bib48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2006-07-030148","article-title":"Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5","volume":"109","author":"de Laat","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s002960050046","article-title":"Detection of anti-recombinant beta 2-glycoprotein 1 and anti-recombinant beta 2-glycoprotein 1 fifth-domain antibodies in sera from patients with systemic lupus erythematosus","volume":"18","author":"Yang","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2016.06.026_bib50","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V87.8.3262.bloodjournal8783262","article-title":"Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system","volume":"87","author":"Igarashi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib51","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","article-title":"Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI","volume":"95","author":"Iverson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2016.06.026_bib52","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.4049\/jimmunol.169.12.7097","article-title":"Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies","volume":"169","author":"Iverson","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2016.06.026_bib53","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","article-title":"Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change","volume":"107","author":"de Laat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib54","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1182\/blood-2010-11-316158","article-title":"Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies","volume":"117","author":"Satta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib55","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib56","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib57","first-page":"51","article-title":"Effect of anticardiolipin\/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome","volume":"25","author":"Robbins","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2016.06.026_bib59","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.06.026_bib60","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2016.06.026_bib61","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib62","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1196\/annals.1422.058","article-title":"C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies","volume":"1108","author":"Romay-Penabad","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.kint.2016.06.026_bib63","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/ndt\/13.10.2645","article-title":"Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome","volume":"13","author":"Rysava","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib64","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00296-008-0779-1","article-title":"Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review","volume":"29","author":"Boltin","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2016.06.026_bib65","first-page":"56","article-title":"Primary antiphospholipid syndrome presented by total infarction of right kidney with nephrotic syndrome","volume":"52","author":"Sa","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib66","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2016.06.026_bib68","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0961203315581207","article-title":"Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II\/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE","volume":"24","author":"Cohen","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib69","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.06.026_bib70","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.00460110","article-title":"Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients","volume":"5","author":"Sinico","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00296-010-1559-2","article-title":"Renal artery stenosis with significant proteinuria may be reversed after nephrectomy or revascularization in patients with the antiphospholipid antibody syndrome: a case series and review of the literature","volume":"32","author":"Peleg","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2016.06.026_bib72","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","article-title":"The expanding spectrum of renal diseases associated with antiphospholipid syndrome","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib73","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000064300","article-title":"A\u00a0rare cause of pulmonary-renal syndrome","volume":"91","author":"Henning","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2016.06.026_bib74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11926-014-0482-z","article-title":"Catastrophic APS in the context of other thrombotic microangiopathies","volume":"17","author":"Rodriguez-Pinto","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.kint.2016.06.026_bib75","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0961203314540764","article-title":"Catastrophic antiphospholipid syndrome: task force report summary","volume":"23","author":"Cervera","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/1319-2442.111064","article-title":"Post-partum bilateral renal cortical necrosis in antiphospholipid syndrome and systemic lupus erythematosus","volume":"24","author":"Vellanki","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.kint.2016.06.026_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0961203310395051","article-title":"Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0961203310397410","article-title":"Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus","volume":"20","author":"Silvarino","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13075-015-0614-5","article-title":"Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up","volume":"17","author":"Gerhardsson","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2016.06.026_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reuma.2008.12.011","article-title":"Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE)","volume":"5","author":"Miranda","year":"2009","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.kint.2016.06.026_bib81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0022-2143(98)90063-4","article-title":"Reactivity patterns of antiphospholipid antibodies and endothelial cells: effect of antiendothelial antibodies on cell migration","volume":"131","author":"Lanir","year":"1998","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.kint.2016.06.026_bib82","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.kint.2016.06.026_bib83","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.34440","article-title":"Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab","volume":"64","author":"Shapira","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib84","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.06.026_bib85","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib86","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMc0910965","article-title":"Eculizumab and renal transplantation in a patient with CAPS","volume":"362","author":"Lonze","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.06.026_bib87","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.06.026_bib88","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN","volume":"23","author":"Herlitz","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hoc.2007.10.002","article-title":"The role of antiphospholipid syndrome in cardiovascular disease","volume":"22","author":"Long","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.kint.2016.06.026_bib90","first-page":"762","article-title":"Antiphospholipid arterial vasculopathy","volume":"16","author":"Alarcon-Segovia","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib91","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.kint.2016.06.026_bib92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.kint.2016.06.026_bib93","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.CIR.99.16.2164","article-title":"Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle","volume":"99","author":"Gallo","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.06.026_bib94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trre.2013.04.002","article-title":"Eculizumab in renal transplantation","volume":"27","author":"Legendre","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.kint.2016.06.026_bib95","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1600-6143.2006.01355.x","article-title":"Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts","volume":"6","author":"Lepin","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib96","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.06.026_bib97","doi-asserted-by":"crossref","first-page":"383.e1","DOI":"10.1016\/j.ahj.2008.11.013","article-title":"Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo","volume":"157","author":"Finn","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.kint.2016.06.026_bib98","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0961203315569336","article-title":"AKT\/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game","volume":"24","author":"Canaud","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00296-013-2900-3","article-title":"Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study","volume":"34","author":"Erre","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.kint.2016.06.026_bib100","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1046\/j.1600-6143.2004.00602.x","article-title":"Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation","volume":"4","author":"Forman","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib101","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.thromres.2013.03.003","article-title":"Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-beta2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients","volume":"131","author":"Hadhri","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.kint.2016.06.026_bib102","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ki.2011.477","article-title":"IgA antibodies against beta2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality","volume":"81","author":"Serrano","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.06.026_bib103","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1681\/ASN.2014030228","article-title":"Association of early kidney allograft failure with preformed IgA antibodies to beta2-glycoprotein I","volume":"26","author":"Morales","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.06.026_bib104","article-title":"The presence of pretransplant antiphospholipid antibodies IgA anti-beta-2-glycoprotein I as a predictor of graft thrombosis after renal transplantation","author":"Morales","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2016.06.026_bib105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/art.1780370219","article-title":"Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus","volume":"37","author":"Warner","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib106","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2016.06.026_bib107","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","article-title":"AKT-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2016.06.026_bib108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0961203306073136","article-title":"New immunosuppresor strategies in the treatment of murine lupus nephritis","volume":"16","author":"Alperovich","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib109","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfn216","article-title":"Rapamycin attenuates the severity of established nephritis in lupus-prone NZB\/W F1 mice","volume":"23","author":"Lui","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ndt\/gfn574","article-title":"Sirolimus interacts with pathways essential for podocyte integrity","volume":"24","author":"Letavernier","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2016.06.026_bib111","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm.3313","article-title":"AKT2 is essential to maintain podocyte viability and function during chronic kidney disease","volume":"19","author":"Canaud","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2016.06.026_bib112","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2006.11.002","article-title":"Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature","volume":"6","author":"Ruffatti","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2016.06.026_bib113","first-page":"1413","article-title":"Hypertension, renal artery stenosis and the \u201cprimary\u201d antiphospholipid syndrome","volume":"18","author":"Asherson","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2016.06.026_bib114","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1523-1755.2002.00500.x","article-title":"\u201cBlack swan in the kidney\u201d: renal involvement in the antiphospholipid antibody syndrome","volume":"62","author":"Nzerue","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.06.026_bib115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rheumatology\/keh490","article-title":"Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation","volume":"44","author":"Sangle","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2016.06.026_bib116","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","article-title":"Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension","volume":"62","author":"Sangle","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2016.06.026_bib117","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1191\/0961203304lu1082oa","article-title":"Antiphospholipid antibodies and hypertension","volume":"13","author":"Rollino","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib118","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1006\/jmcc.2000.1234","article-title":"Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction","volume":"32","author":"Remondino","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.kint.2016.06.026_bib119","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1191\/0961203306lu2335oa","article-title":"Stenosis in antiphospholipid syndrome: a new finding with clinical implications","volume":"15","author":"Ben-Ami","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2016.06.026_bib120","doi-asserted-by":"crossref","first-page":"1796.e9","DOI":"10.1016\/j.avsg.2014.04.017","article-title":"Severe symptomatic stenosis of visceral and renal arteries leading primary antiphospholipid syndrome diagnosis","volume":"28","author":"Salaun","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.kint.2016.06.026_bib121","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1111\/ped.12135","article-title":"Co-existence of renovascular hypertension, polyarteritis nodosa, antiphospholipid syndrome and methylenetetrahydrofolate reductase mutation","volume":"55","author":"Yildiz","year":"2013","journal-title":"Pediatr Int"},{"key":"10.1016\/j.kint.2016.06.026_bib122","first-page":"417","article-title":"[Renovascular hypertension associated with antiphospholipid antibodies in a woman with systemic lupus erythematosus]","volume":"38","author":"Serino","year":"1996","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"10.1016\/j.kint.2016.06.026_bib123","first-page":"276","article-title":"[Antiphospholipid syndrome and vascular disease]","volume":"138","author":"Linhartova","year":"1999","journal-title":"Cas Lek Cesk"},{"key":"10.1016\/j.kint.2016.06.026_bib124","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1253\/jcj.64.541","article-title":"Renovascular hypertension observed in a patient with antiphospholipid-antibody syndrome","volume":"64","author":"Aizawa","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.kint.2016.06.026_bib125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00296-009-0922-7","article-title":"Primary antiphospholipid syndrome presenting as hyponatremic hypertensive syndrome and acute adrenal insufficiency following it: a rare case","volume":"30","author":"Kurtulmus","year":"2009","journal-title":"Rheumatol Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816303179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816303179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:44:57Z","timestamp":1749559497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816303179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0085253816303179"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.06.026","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid syndrome and kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}